Dr. Farber is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
333 Cedar St., Fmp 113
New Haven, CT 06520Phone+1 203-785-4191Fax+1 203-785-3788
Education & Training
- Boston University Medical CenterResidency, Internal Medicine, 1965 - 1967
- State University of New York Downstate Medical Center College of MedicineClass of 1965
Certifications & Licensure
- CT State Medical License 1971 - 2017
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Publications & Presentations
PubMed
- 42 citationsToxicity and activity of a twice daily high-dose bolus interleukin 2 regimen in patients with metastatic melanoma and metastatic renal cell cancer.Nicolas Acquavella, Harriet M. Kluger, John Rhee, Leonard R. Farber, Harold Tara
Journal of Immunotherapy. 2008-07-01 - 7 citationsFive-year update of an expanded phase II study of dose-dense and -intense doxorubicin, paclitaxel and cyclophosphamide (ATC) in high-risk breast cancer.Maysa M. Abu-Khalaf, Stephen Windsor, Keita Ebisu, Saritha Salikooti, Gowri Ananthanarayanan
Oncology. 2005-01-01 - 28 citationsReliability of identification of 655 sentinel lymph nodes in 263 consecutive patients with malignant melanoma.Stephan Ariyan, Charlotte E. Ariyan, Leonard R. Farber, David S. Fischer, Stuart D. Flynn
Journal of the American College of Surgeons. 2004-06-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: